NCT00026663View on ClinicalTrials.gov

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

August 9, 2000

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Renal Cell CarcinomaLung CarcinomaCervical Carcinoma
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00026663 - Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance | Biotech Hunter | Biotech Hunter